141333-36-0,MFCD09834353
Catalog No.:AA001G5H

141333-36-0 | 3-(Cyclopentyloxy)-4-methoxyphenylacetonitrile

Pack Size
Purity
Availability
Price(USD)
Quantity
  
100mg
95%
in stock  
$106.00   $74.00
- +
250mg
95%
in stock  
$190.00   $133.00
- +
500mg
95%
in stock  
$270.00   $189.00
- +
1g
95%
in stock  
$380.00   $266.00
- +
2g
95%
in stock  
$713.00   $500.00
- +
5g
95%
in stock  
$1,142.00   $799.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA001G5H
Chemical Name:
3-(Cyclopentyloxy)-4-methoxyphenylacetonitrile
CAS Number:
141333-36-0
Molecular Formula:
C14H17NO2
Molecular Weight:
231.2903
MDL Number:
MFCD09834353
SMILES:
N#CCc1ccc(c(c1)OC1CCCC1)OC
Properties
Computed Properties
 
Complexity:
277  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
17  
Hydrogen Bond Acceptor Count:
3  
Rotatable Bond Count:
4  
XLogP3:
2.4  

Downstream Synthesis Route

[1]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-US6337408,2002,B1Locationinpatent:Example5

[2]CurrentPatentAssignee:GLENMARKPHARMACEUTICALSLTD-WO2004/16596,2004,A1Locationinpatent:Page43

[3]Christensen,SiegfriedB.;Guider,Aimee;Forster,CorneliaJ.;Gleason,JohnG.;Bender,PaulE.;Karpinski,JosephM.;DewolfJr.,WalterE.;Barnette,MaryS.;Underwood,DavidC.;Griswold,DonE.;Cieslinski,LenoraB.;Burman,Miriam;Bochnowicz,Steven;Osborn,RuthR.;Manning,CarolD.;Grous,Marilyn;Hillegas,LeonardM.;Bartus,JoanO'Leary;DominicRyan;Eggleston,DrakeS.;CurtisHaltiwanger;Torphy,TheodoreJ.[JournalofMedicinalChemistry,1998,vol.41,#6,p.821-835]

[4]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-US5449686,1995,A

[5]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-US5602173,1997,A

[6]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-US5605923,1997,A

[7]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-US6013827,2000,A

[1]Andres,JIgnacio;Alonso,JoseM;Diaz,Adolfo;Fernandez,Javier;Iturrino,Laura;Martinez,Pedro;Matesanz,Encarna;Freyne,EddyJ;Deroose,Frederik;Boeckx,Gustaaf;Petit,Davy;Diels,Gaston;Megens,Anton;Somers,Marijke;VanWauwe,Jean;Stoppie,Paul;Cools,Marina;DeClerck,Fred;Peeters,Danielle;deChaffoy,Didier[Bioorganicandmedicinalchemistryletters,2002,vol.12,#4,p.653-658]

[2]CurrentPatentAssignee:JOHNSON&JOHNSONINC-US5994376,1999,A

[1]Andres,JIgnacio;Alonso,JoseM;Diaz,Adolfo;Fernandez,Javier;Iturrino,Laura;Martinez,Pedro;Matesanz,Encarna;Freyne,EddyJ;Deroose,Frederik;Boeckx,Gustaaf;Petit,Davy;Diels,Gaston;Megens,Anton;Somers,Marijke;VanWauwe,Jean;Stoppie,Paul;Cools,Marina;DeClerck,Fred;Peeters,Danielle;deChaffoy,Didier[Bioorganicandmedicinalchemistryletters,2002,vol.12,#4,p.653-658]

[1]Ochiai,Hiroshi;Ohtani,Tazumi;Ishida,Akiharu;Kusumi,Kensuke;Kato,Masashi;Kohno,Hiroshi;Odagaki,Yoshihiko;Kishikawa,Katuya;Yamamoto,Susumu;Takeda,Hiroshi;Obata,Takaaki;Nakai,Hisao;Toda,Masaaki[BioorganicandMedicinalChemistry,2004,vol.12,#17,p.4645-4665]

[2]Ochiai,Hiroshi;Ohtani,Tazumi;Ishida,Akiharu;Kusumi,Kensuke;Kato,Masashi;Kohno,Hiroshi;Kishikawa,Katuya;Obata,Takaaki;Nakai,Hisao;Toda,Masaaki[BioorganicandMedicinalChemistryLetters,2004,vol.14,#1,p.207-210]

[1]Ochiai,Hiroshi;Ohtani,Tazumi;Ishida,Akiharu;Kusumi,Kensuke;Kato,Masashi;Kohno,Hiroshi;Kishikawa,Katuya;Obata,Takaaki;Nakai,Hisao;Toda,Masaaki[BioorganicandMedicinalChemistryLetters,2004,vol.14,#1,p.207-210]

[2]Ochiai,Hiroshi;Ohtani,Tazumi;Ishida,Akiharu;Kusumi,Kensuke;Kato,Masashi;Kohno,Hiroshi;Odagaki,Yoshihiko;Kishikawa,Katuya;Yamamoto,Susumu;Takeda,Hiroshi;Obata,Takaaki;Nakai,Hisao;Toda,Masaaki[BioorganicandMedicinalChemistry,2004,vol.12,#17,p.4645-4665]

[3]CurrentPatentAssignee:ONOPHARMACEUTICALCOLTD-US2004/44036,2004,A1Locationinpatent:Page/Pagecolumn16

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 141333-36-0
Tags:141333-36-0 Molecular Formula|141333-36-0 MDL|141333-36-0 SMILES|141333-36-0 3-(Cyclopentyloxy)-4-methoxyphenylacetonitrile
Catalog No.: AA001G5H
141333-36-0,MFCD09834353
141333-36-0 | 3-(Cyclopentyloxy)-4-methoxyphenylacetonitrile
Pack Size: 100mg
Purity: 95%
in stock
$106.00 $74.00
Pack Size: 250mg
Purity: 95%
in stock
$190.00 $133.00
Pack Size: 500mg
Purity: 95%
in stock
$270.00 $189.00
Pack Size: 1g
Purity: 95%
in stock
$380.00 $266.00
Pack Size: 2g
Purity: 95%
in stock
$713.00 $500.00
Pack Size: 5g
Purity: 95%
in stock
$1,142.00 $799.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA001G5H
Chemical Name: 3-(Cyclopentyloxy)-4-methoxyphenylacetonitrile
CAS Number: 141333-36-0
Molecular Formula: C14H17NO2
Molecular Weight: 231.2903
MDL Number: MFCD09834353
SMILES: N#CCc1ccc(c(c1)OC1CCCC1)OC
Properties
Complexity: 277  
Covalently-Bonded Unit Count: 1  
Heavy Atom Count: 17  
Hydrogen Bond Acceptor Count: 3  
Rotatable Bond Count: 4  
XLogP3: 2.4  
Downstream Synthesis Route
292638-85-8    141333-36-0    152630-48-3 

[1]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-US6337408,2002,B1Locationinpatent:Example5

[2]CurrentPatentAssignee:GLENMARKPHARMACEUTICALSLTD-WO2004/16596,2004,A1Locationinpatent:Page43

[3]Christensen,SiegfriedB.;Guider,Aimee;Forster,CorneliaJ.;Gleason,JohnG.;Bender,PaulE.;Karpinski,JosephM.;DewolfJr.,WalterE.;Barnette,MaryS.;Underwood,DavidC.;Griswold,DonE.;Cieslinski,LenoraB.;Burman,Miriam;Bochnowicz,Steven;Osborn,RuthR.;Manning,CarolD.;Grous,Marilyn;Hillegas,LeonardM.;Bartus,JoanO'Leary;DominicRyan;Eggleston,DrakeS.;CurtisHaltiwanger;Torphy,TheodoreJ.[JournalofMedicinalChemistry,1998,vol.41,#6,p.821-835]

[4]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-US5449686,1995,A

[5]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-US5602173,1997,A

[6]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-US5605923,1997,A

[7]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-US6013827,2000,A

106-93-4    141333-36-0    183660-31-3 

[1]Andres,JIgnacio;Alonso,JoseM;Diaz,Adolfo;Fernandez,Javier;Iturrino,Laura;Martinez,Pedro;Matesanz,Encarna;Freyne,EddyJ;Deroose,Frederik;Boeckx,Gustaaf;Petit,Davy;Diels,Gaston;Megens,Anton;Somers,Marijke;VanWauwe,Jean;Stoppie,Paul;Cools,Marina;DeClerck,Fred;Peeters,Danielle;deChaffoy,Didier[Bioorganicandmedicinalchemistryletters,2002,vol.12,#4,p.653-658]

[2]CurrentPatentAssignee:JOHNSON&JOHNSONINC-US5994376,1999,A

141333-36-0    141332-75-4 

[1]Andres,JIgnacio;Alonso,JoseM;Diaz,Adolfo;Fernandez,Javier;Iturrino,Laura;Martinez,Pedro;Matesanz,Encarna;Freyne,EddyJ;Deroose,Frederik;Boeckx,Gustaaf;Petit,Davy;Diels,Gaston;Megens,Anton;Somers,Marijke;VanWauwe,Jean;Stoppie,Paul;Cools,Marina;DeClerck,Fred;Peeters,Danielle;deChaffoy,Didier[Bioorganicandmedicinalchemistryletters,2002,vol.12,#4,p.653-658]

1476-11-5    141333-36-0    401518-81-8 

[1]Ochiai,Hiroshi;Ohtani,Tazumi;Ishida,Akiharu;Kusumi,Kensuke;Kato,Masashi;Kohno,Hiroshi;Odagaki,Yoshihiko;Kishikawa,Katuya;Yamamoto,Susumu;Takeda,Hiroshi;Obata,Takaaki;Nakai,Hisao;Toda,Masaaki[BioorganicandMedicinalChemistry,2004,vol.12,#17,p.4645-4665]

[2]Ochiai,Hiroshi;Ohtani,Tazumi;Ishida,Akiharu;Kusumi,Kensuke;Kato,Masashi;Kohno,Hiroshi;Kishikawa,Katuya;Obata,Takaaki;Nakai,Hisao;Toda,Masaaki[BioorganicandMedicinalChemistryLetters,2004,vol.14,#1,p.207-210]

141333-36-0    401518-11-4    401518-12-5 

[1]Ochiai,Hiroshi;Ohtani,Tazumi;Ishida,Akiharu;Kusumi,Kensuke;Kato,Masashi;Kohno,Hiroshi;Kishikawa,Katuya;Obata,Takaaki;Nakai,Hisao;Toda,Masaaki[BioorganicandMedicinalChemistryLetters,2004,vol.14,#1,p.207-210]

[2]Ochiai,Hiroshi;Ohtani,Tazumi;Ishida,Akiharu;Kusumi,Kensuke;Kato,Masashi;Kohno,Hiroshi;Odagaki,Yoshihiko;Kishikawa,Katuya;Yamamoto,Susumu;Takeda,Hiroshi;Obata,Takaaki;Nakai,Hisao;Toda,Masaaki[BioorganicandMedicinalChemistry,2004,vol.12,#17,p.4645-4665]

[3]CurrentPatentAssignee:ONOPHARMACEUTICALCOLTD-US2004/44036,2004,A1Locationinpatent:Page/Pagecolumn16

Building Blocks More >
1416352-01-6
1416352-01-6
1,2,3,4-Tetrahydro-2,6-naphthyridine hydrochloride
AA001GNM | MFCD22421586
1417640-16-4
1417640-16-4
1(2H)-Isoquinolinone, 7-(4-pyridinyl)-
AA001GXI | MFCD17926326
14202-62-1
14202-62-1
2,2-Diethylpentan-1-ol
AA001HHW | MFCD00085547
1422051-73-7
1422051-73-7
(R)-3-Amino-4,4-dimethyl-pentanoic acid methyl ester, HCl
AA001HVV | MFCD12068631
14381-42-1
14381-42-1
2,3-Dihydro-1H-indene-1-carboxylic acid
AA001ICB | MFCD00021239
14405-48-2
14405-48-2
Copper, bis(1,3-diphenyl-1,3-propanedionato-κO1,κO3)-, (SP-4-1)-
AA001IRZ | MFCD00270927
1443437-74-8
1443437-74-8
3-Piperidinecarboxamide, N-(4-chlorophenyl)-1-[3-(2-furanyl)benzoyl]-
AA001JAL | MFCD28166491
1446016-91-6
1446016-91-6
4-Chloro-3-(trifluoromethyl)phenyl triflate
AA001JR3 | MFCD25541859
14482-51-0
14482-51-0
2-Bromo-3,5-dichloropyridine
AA001K5D | MFCD00233990
14507-51-8
14507-51-8
18,19-Dinorpregna-2,5(10)-dien-20-yn-17-ol, 13-ethyl-3-methoxy-, (17α)-
AA001KH0
Submit
© 2017 AA BLOCKS, INC. All rights reserved.